Chemoinformaics analysis of P-HYDROXYCINNAMIC-ACID
| Molecular Weight | 268.268 | nRot | 4 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 15 |
| Exact Molecular Weight | 268.074 | nRing | 2 |
| Solubility: LogS | -4.283 | nHRing | 0 |
| Solubility: LogP | 3.566 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 37.9295 |
| nHD | 1 | BPOL | 15.5105 |
| QED | 0.526 |
| Synth | 1.68 |
| Natural Product Likeliness | 0.047 |
| NR-PPAR-gamma | 0.272 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.013 |
| CACO-2 | -4.694 |
| MDCK | 0.0000184 |
| BBB | 0.746 |
| PPB | 0.997821 |
| VDSS | 0.218 |
| FU | 0.00595776 |
| CYP1A2-inh | 0.201 |
| CYP1A2-sub | 0.045 |
| CYP2c19-inh | 0.084 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.502 |
| CYP2c9-sub | 0.261 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.076 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.111 |
| CL | 1.334 |
| T12 | 0.882 |
| hERG | 0.118 |
| Ames | 0.013 |
| ROA | 0.023 |
| SkinSen | 0.967 |
| Carcinogencity | 0.075 |
| EI | 0.935 |
| Respiratory | 0.471 |
| NR-Aromatase | 0.023 |
| Antiviral | No |
| Prediction | 0.722715 |